A potent, non-nucleoside reverse transcriptase inhibitor (NNRTI) used in combination with nucleoside analogues for treatment of Human Immunodeficiency Virus Type 1 (HIV-1) infection and AIDS. Structurally, nevirapine belongs to the dipyridodiazepinone chemical class.
For use in combination with other antiretroviral drugs in the ongoing treatment of HIV-1 infection.
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.